Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida
Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week.
Picking the Right Partner from Product and Process Development Through Commercialization
- Qualifying how you choose your raw and starting material provider
- Increase your commercialization success rates through standardized methods, access to a diverse and recallable donor pool, and reduce outcome variability
• Choosing a complete partner for primary source material for research use, pre-clinical evaluation, and clinical GMP compliant cellular products
